VERTEX PHARMACEUTICALS INC

Vertex (VRTX) shares rose 2% to $525.86, reaching a $133B market cap, with 24‑hour volume of $878.3M and 3.65% monthly gain. See the latest trading, corporate filings and comparative stock performance.

Discover why Vertex Pharmaceuticals is outpacing rivals—stable cash flow, a high‑impact therapeutic pipeline, and a steady price climb amid market turbulence.

Explore Vertex’s 2026 market snapshot: 2.53% gain, $524.43 price, biotech leader with strong pipeline and dividend appeal. Invest with confidence.